Works about ACUTE myeloid leukemia

Results: 5000
    1

    Measurable residual disease (MRD) as a surrogate end point for clinical drug approval in acute myeloid leukemia (AML): Perspectives from the MRD Partnership and Alliance in AML Clinical Treatment Consortium.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 13, p. 1, doi. 10.1002/cncr.35960
    By:
    • Boyiadzis, Michael;
    • Wei, Andrew H.;
    • Paiva, Bruno;
    • Freeman, Sylvie D.;
    • Kaspers, Gertjan;
    • Chyla, Brenda;
    • Hersey, Sarah;
    • Patel, Reshma;
    • Maloney, Brian;
    • Blanchet Zumofen, Marie‐Helene;
    • Van Hoef, Marlies;
    • Wulff, Beate;
    • Obourn, Vanessa;
    • Patel, Shalaka;
    • Lopes de Menezes, Daniel;
    • Shi, Qian;
    • Bengoudifa, Bourras‐Rezki;
    • Dimier, Natalie;
    • Prior, Thomas J.;
    • Roboz, Gail J.
    Publication type:
    Article
    2
    3
    4
    5
    6

    Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletions.

    Published in:
    Leukemia & Lymphoma, 2025, v. 66, n. 7, p. 1221, doi. 10.1080/10428194.2025.2477723
    By:
    • Kugler, Eitan;
    • Dasdemir, Enes;
    • Bataller, Alex;
    • Wang, Bofei;
    • DiNardo, Courtney D.;
    • Daver, Naval;
    • Yilmaz, Musa;
    • Short, Nicholas J.;
    • Borthakur, Gautam;
    • Kadia, Tapan M.;
    • Sasaki, Koji;
    • Hammond, Danielle;
    • Bazinet, Alexandre;
    • Irajizad, Ehsan;
    • Thakral, Beenu;
    • Pierce, Sherry;
    • Reville, Patrick;
    • Ravandi, Farhad;
    • Abbas, Hussein A.
    Publication type:
    Article
    7
    8

    Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adults.

    Published in:
    Leukemia & Lymphoma, 2025, v. 66, n. 7, p. 1234, doi. 10.1080/10428194.2025.2476655
    By:
    • Amrein, Philip C.;
    • Preffer, Frederic I.;
    • Fell, Geoffrey;
    • Attar, Eyal C.;
    • Narayan, Rupa;
    • Blonquist, Traci M.;
    • Brunner, Andrew M.;
    • Hobbs, Gabriela S.;
    • Hock, Hanno R.;
    • McAfee, Steven L.;
    • Moran, Jenna A.;
    • Bergeron, Meghan K.;
    • Foster, Julia E.;
    • Bertoli, Christina;
    • McGregor, Kristin;
    • Connolly, Christine;
    • Behnan, Tanya T.;
    • Som, Tina T.;
    • Ramos, Aura Y.;
    • Vartanian, Megan K.
    Publication type:
    Article
    9

    Comparable outcomes with 14-, 21-, or standard 28-day venetoclax in the first cycle of azacitidine–venetoclax in untreated acute myeloid leukemia: real-world experience from the Hokkaido Leukemia Net.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01324-7
    By:
    • Kanaya, Minoru;
    • Onozawa, Masahiro;
    • Matsukawa, Toshihiro;
    • Miyashita, Naoki;
    • Fujii, Fumiaki;
    • Yoshida, Shota;
    • Nagai, Jun;
    • Aiba, Masayuki;
    • Hidaka, Daisuke;
    • Hashiguchi, Junichi;
    • Senjo, Hajime;
    • Igarashi, Tetsuyuki;
    • Chiba, Masahiro;
    • Yamamoto, Satoshi;
    • Shimizu, Taku;
    • Ishio, Takashi;
    • Yokoyama, Shota;
    • Ebata, Ko;
    • Iyama, Satoshi;
    • Oyake, Tatsuo
    Publication type:
    Article
    10
    11
    12

    Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AML.

    Published in:
    NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-01013-5
    By:
    • Watts, Justin;
    • Nong, Tiffany;
    • Micin, Katarina;
    • Soong, Deborah;
    • Madarang, Ellen;
    • Affer, Maurizio;
    • Mehra, Shefali;
    • Lesmes, Jessica Alvarez;
    • Chapman, Jennifer;
    • Zhou, Yi;
    • Thomassen, Amber;
    • Bradley, Terrence;
    • Totiger, Tulasigeri;
    • Swords, Ronan;
    • Taylor, Justin
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Correction: Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion.

    Published in:
    2025
    By:
    • Koster, Eva A. S.;
    • Bonneville, Edouard F.;
    • von dem Borne, Peter A.;
    • van Balen, Peter;
    • Marijt, Erik W. A.;
    • Tjon, Jennifer M. L.;
    • Snijders, Tjeerd J. F.;
    • van Lammeren, Daniëlle;
    • Veelken, Hendrik;
    • Putter, Hein;
    • Falkenburg, J. H. Frederik;
    • Halkes, Constantijn J. M.;
    • de Wreede, Liesbeth C.
    Publication type:
    Correction Notice
    24

    Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion.

    Published in:
    Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2023.1208814
    By:
    • Koster, Eva A. S.;
    • Bonneville, Edouard F.;
    • von dem Borne, Peter A.;
    • van Balen, Peter;
    • Marijt, Erik W. A.;
    • Tjon, Jennifer M. L.;
    • Snijders, Tjeerd J. F.;
    • van Lammeren, Daniëlle;
    • Veelken, Hendrik;
    • Putter, Hein;
    • Falkenburg, J. H. Frederik;
    • Halkes, Constantijn J. M.;
    • de Wreede, Liesbeth C.
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Efficacy and prognostic analysis of venetoclax combined with hypomethylating agents for induction therapy in acute myeloid leukemia: a multi-center real-world study on indication-specific stratification, molecular markers, and hematologic toxicities.

    Published in:
    Cancer Cell International, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12935-025-03858-z
    By:
    • Xia, Leiming;
    • Qu, Mengni;
    • Ge, Ling;
    • Chen, Yingying;
    • Zhou, Beibei;
    • Shi, Ting;
    • Liu, Yang;
    • Ruan, Min;
    • Xia, Liang;
    • Hong, Jian;
    • Li, Jianjun;
    • Qian, Wei;
    • Zhang, Yu;
    • Jiang, Lei;
    • Zhao, Yiming;
    • Tian, Wanlu;
    • Huang, Zhenqi;
    • Jin, Fengbo;
    • Ge, Jian;
    • Yang, Mingzhen
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Low Rate of Invasive Fungal Infections During Induction and Consolidation Chemotherapy for Adults with De Novo Acute Myeloid Leukemia Without Anti-mold Prophylaxis: Single-Center 2002–2018 Empirical/Pre-emptive Approach.

    Published in:
    Mycopathologia, 2020, v. 185, n. 4, p. 639, doi. 10.1007/s11046-020-00461-w
    By:
    • Martino, Rodrigo;
    • Garrido, Ana;
    • Santaliestra, Marta;
    • García-Cadenas, Irene;
    • Novelli, Silvana;
    • Saavedra, Silvanna Daniella;
    • Esquirol, Albert;
    • Granell, Miquel;
    • Briones, Javier;
    • Moreno, Carolina;
    • Brunet, Salut;
    • Giménez, Ana;
    • Hidalgo, Alberto;
    • Sánchez, Fernando;
    • Sierra, Jorge
    Publication type:
    Article
    49
    50